TABLE 1

BP Values (mL/mL) in Control Subjects and Patients with TLE Before and After PVC

RegionBefore PVCAfter PVC
ControlsPatientsPControlsPatientsP
I. Superior temporal45 ± 1532 ± 1288 ± 2576 ± 32
C. Superior temporal46 ± 1336 ± 1484 ± 2373 ± 27
I. Middle temporal51 ± 1737 ± 1295 ± 2879 ± 29
C. Middle temporal52 ± 1341 ± 1591 ± 2377 ± 25
I. Inferior temporal52 ± 1838 ± 12100 ± 2978 ± 28
C. Inferior temporal54 ± 1646 ± 1697 ± 2590 ± 32
I. Fusiform gyrus73 ± 2245 ± 15126 ± 3480 ± 24
C. Fusiform gyrus71 ± 2355 ± 19120 ± 3296 ± 32
I. Parahippocampus90 ± 2647 ± 16144 ± 3883 ± 27
C. Parahippocampus86 ± 2359 ± 17144 ± 41102 ± 30
I. Hippocampus88 ± 2137 ± 17127 ± 2864 ± 31
C. Hippocampus85 ± 2458 ± 16124 ± 3497 ± 30
I. Amygdala54 ± 1433 ± 1572 ± 1650 ± 20
C. Amygdala53 ± 1442 ± 1675 ± 1660 ± 22
I. Frontal35 ± 1131 ± 1168 ± 1766 ± 24
C. Frontal34 ± 1030 ± 1165 ± 1663 ± 23
I. Parietal32 ± 1026 ± 963 ± 1764 ± 22
C. Parietal31 ± 1027 ± 1162 ± 1866 ± 24
I. Insula56 ± 1638 ± 1395 ± 2763 ± 21
C. Insula55 ± 1540 ± 1495 ± 2766 ± 21
I. Occipital19 ± 617 ± 639 ± 1044 ± 14
C. Occipital18 ± 417 ± 637 ± 846 ± 17
Raphe54 ± 1338 ± 13N/AN/AN/A
  • * Uncorrected P < 0.05, controls vs. patients, unpaired t test.

  • P < 0.05 after correction for multiple region comparisons, controls vs. patients, unpaired t test.

  • I. = ipsilateral to seizure focus; C. = contralateral to seizure focus; N/A = not available.